APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etoricoxib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Etoricoxib Market Analysis and Forecast 2026-2032

2 January 2026192 pages

Choose your research edition.

Industry ResearchEtoricoxib Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Etoricoxib Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Etoricoxib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etoricoxib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Etoricoxib Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Etoricoxib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Etoricoxib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Etoricoxib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Etoricoxib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Etoricoxib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Etoricoxib include Shanghai Shyndec Pharmaceutical, Qilu Pharmaceutical, Merck & Co, Easton Biopharmaceuticals, Beijing Tide Pharmaceutical, Morepen Laboratories, Metrochem API, Hema Pharmaceuticals and Frosst Iberica SA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Etoricoxib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Etoricoxib, also provides the sales of main regions and countries. Of the upcoming market potential for Etoricoxib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Etoricoxib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Etoricoxib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Etoricoxib sales, projected growth trends, production technology, application and end-user industry.

Etoricoxib Segment by Company

Shanghai Shyndec Pharmaceutical

Qilu Pharmaceutical

Merck & Co

Easton Biopharmaceuticals

Beijing Tide Pharmaceutical

Morepen Laboratories

Metrochem API

Hema Pharmaceuticals

Frosst Iberica SA

Atom Pharma

Etoricoxib Segment by Type

120 mg

30 mg

60 mg

90 mg

Etoricoxib Segment by Application

Hospital

Pharmacy

Others

Etoricoxib Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etoricoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etoricoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etoricoxib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Etoricoxib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Etoricoxib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Etoricoxib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Etoricoxib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 120 mg Major Manufacturers Table 3. 30 mg Major Manufacturers Table 4. 60 mg Major Manufacturers Table 5. 90 mg Major Manufacturers Table 6. Global Etoricoxib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Pharmacy Major Manufacturers Table 9. Others Major Manufacturers Table 10. Etoricoxib Industry Trends Table 11. Etoricoxib Industry Drivers Table 12. Etoricoxib Industry Opportunities and Challenges Table 13. Etoricoxib Industry Restraints Table 14. Global Etoricoxib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Etoricoxib Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Etoricoxib Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Etoricoxib Revenue Market Share by Region (2021-2026) Table 18. Global Etoricoxib Revenue Market Share by Region (2027-2032) Table 19. Global Etoricoxib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Etoricoxib Sales by Region (2021-2026) & (K Units) Table 21. Global Etoricoxib Sales by Region (2027-2032) & (K Units) Table 22. Global Etoricoxib Sales Market Share by Region (2021-2026) Table 23. Global Etoricoxib Sales Market Share by Region (2027-2032) Table 24. Global Etoricoxib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Etoricoxib Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Etoricoxib Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Etoricoxib Sales Market Share by Manufacturers (2021-2026) Table 28. Global Etoricoxib Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Etoricoxib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Etoricoxib Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Etoricoxib Manufacturers, Product Type & Application Table 32. Global Etoricoxib Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Etoricoxib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Etoricoxib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Etoricoxib Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Etoricoxib Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Etoricoxib Revenue Market Share by Type (2021-2026) Table 39. Global Etoricoxib Revenue Market Share by Type (2027-2032) Table 40. Global Etoricoxib Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Etoricoxib Sales by Type (2021-2026) & (K Units) Table 42. Global Etoricoxib Sales by Type (2027-2032) & (K Units) Table 43. Global Etoricoxib Sales Market Share by Type (2021-2026) Table 44. Global Etoricoxib Sales Market Share by Type (2027-2032) Table 45. Global Etoricoxib Price by Type (2021-2026) & (US$/Unit) Table 46. Global Etoricoxib Price by Type (2027-2032) & (US$/Unit) Table 47. Global Etoricoxib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Etoricoxib Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Etoricoxib Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Etoricoxib Revenue Market Share by Application (2021-2026) Table 51. Global Etoricoxib Revenue Market Share by Application (2027-2032) Table 52. Global Etoricoxib Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Etoricoxib Sales by Application (2021-2026) & (K Units) Table 54. Global Etoricoxib Sales by Application (2027-2032) & (K Units) Table 55. Global Etoricoxib Sales Market Share by Application (2021-2026) Table 56. Global Etoricoxib Sales Market Share by Application (2027-2032) Table 57. Global Etoricoxib Price by Application (2021-2026) & (US$/Unit) Table 58. Global Etoricoxib Price by Application (2027-2032) & (US$/Unit) Table 59. Shanghai Shyndec Pharmaceutical Company Information Table 60. Shanghai Shyndec Pharmaceutical Business Overview Table 61. Shanghai Shyndec Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolio Table 63. Shanghai Shyndec Pharmaceutical Recent Development Table 64. Qilu Pharmaceutical Company Information Table 65. Qilu Pharmaceutical Business Overview Table 66. Qilu Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Qilu Pharmaceutical Etoricoxib Product Portfolio Table 68. Qilu Pharmaceutical Recent Development Table 69. Merck & Co Company Information Table 70. Merck & Co Business Overview Table 71. Merck & Co Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Merck & Co Etoricoxib Product Portfolio Table 73. Merck & Co Recent Development Table 74. Easton Biopharmaceuticals Company Information Table 75. Easton Biopharmaceuticals Business Overview Table 76. Easton Biopharmaceuticals Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Easton Biopharmaceuticals Etoricoxib Product Portfolio Table 78. Easton Biopharmaceuticals Recent Development Table 79. Beijing Tide Pharmaceutical Company Information Table 80. Beijing Tide Pharmaceutical Business Overview Table 81. Beijing Tide Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Beijing Tide Pharmaceutical Etoricoxib Product Portfolio Table 83. Beijing Tide Pharmaceutical Recent Development Table 84. Morepen Laboratories Company Information Table 85. Morepen Laboratories Business Overview Table 86. Morepen Laboratories Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Morepen Laboratories Etoricoxib Product Portfolio Table 88. Morepen Laboratories Recent Development Table 89. Metrochem API Company Information Table 90. Metrochem API Business Overview Table 91. Metrochem API Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Metrochem API Etoricoxib Product Portfolio Table 93. Metrochem API Recent Development Table 94. Hema Pharmaceuticals Company Information Table 95. Hema Pharmaceuticals Business Overview Table 96. Hema Pharmaceuticals Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hema Pharmaceuticals Etoricoxib Product Portfolio Table 98. Hema Pharmaceuticals Recent Development Table 99. Frosst Iberica SA Company Information Table 100. Frosst Iberica SA Business Overview Table 101. Frosst Iberica SA Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Frosst Iberica SA Etoricoxib Product Portfolio Table 103. Frosst Iberica SA Recent Development Table 104. Atom Pharma Company Information Table 105. Atom Pharma Business Overview Table 106. Atom Pharma Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Atom Pharma Etoricoxib Product Portfolio Table 108. Atom Pharma Recent Development Table 109. North America Etoricoxib Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Etoricoxib Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Etoricoxib Sales by Type (2021-2026) & (K Units) Table 112. North America Etoricoxib Sales by Type (2027-2032) & (K Units) Table 113. North America Etoricoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 114. North America Etoricoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 115. North America Etoricoxib Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Etoricoxib Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Etoricoxib Sales by Application (2021-2026) & (K Units) Table 118. North America Etoricoxib Sales by Application (2027-2032) & (K Units) Table 119. North America Etoricoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 120. North America Etoricoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 121. North America Etoricoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Etoricoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America Etoricoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America Etoricoxib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. North America Etoricoxib Sales by Country (2021-2026) & (K Units) Table 126. North America Etoricoxib Sales by Country (2027-2032) & (K Units) Table 127. North America Etoricoxib Sales Price by Country (2021-2026) & (US$/Unit) Table 128. North America Etoricoxib Sales Price by Country (2027-2032) & (US$/Unit) Table 129. United States Etoricoxib Revenue (2021-2032) & (US$ Million) Table 130. Canada Etoricoxib Revenue (2021-2032) & (US$ Million) Table 131. Europe Etoricoxib Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Etoricoxib Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Etoricoxib Sales by Type (2021-2026) & (K Units) Table 134. Europe Etoricoxib Sales by Type (2027-2032) & (K Units) Table 135. Europe Etoricoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Europe Etoricoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Europe Etoricoxib Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Etoricoxib Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Etoricoxib Sales by Application (2021-2026) & (K Units) Table 140. Europe Etoricoxib Sales by Application (2027-2032) & (K Units) Table 141. Europe Etoricoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Europe Etoricoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Europe Etoricoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Etoricoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Etoricoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Etoricoxib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Europe Etoricoxib Sales by Country (2021-2026) & (K Units) Table 148. Europe Etoricoxib Sales by Country (2027-2032) & (K Units) Table 149. Europe Etoricoxib Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Europe Etoricoxib Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Germany Etoricoxib Revenue (2021-2032) & (US$ Million) Table 152. France Etoricoxib Revenue (2021-2032) & (US$ Million) Table 153. U.K. Etoricoxib Revenue (2021-2032) & (US$ Million) Table 154. Italy Etoricoxib Revenue (2021-2032) & (US$ Million) Table 155. Netherlands Etoricoxib Revenue (2021-2032) & (US$ Million) Table 156. China Etoricoxib Revenue by Type (2021-2026) & (US$ Million) Table 157. China Etoricoxib Revenue by Type (2027-2032) & (US$ Million) Table 158. China Etoricoxib Sales by Type (2021-2026) & (K Units) Table 159. China Etoricoxib Sales by Type (2027-2032) & (K Units) Table 160. China Etoricoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 161. China Etoricoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 162. China Etoricoxib Revenue by Application (2021-2026) & (US$ Million) Table 163. China Etoricoxib Revenue by Application (2027-2032) & (US$ Million) Table 164. China Etoricoxib Sales by Application (2021-2026) & (K Units) Table 165. China Etoricoxib Sales by Application (2027-2032) & (K Units) Table 166. China Etoricoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 167. China Etoricoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Etoricoxib Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Etoricoxib Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Etoricoxib Sales by Type (2021-2026) & (K Units) Table 171. Asia Etoricoxib Sales by Type (2027-2032) & (K Units) Table 172. Asia Etoricoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Asia Etoricoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Asia Etoricoxib Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Etoricoxib Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Etoricoxib Sales by Application (2021-2026) & (K Units) Table 177. Asia Etoricoxib Sales by Application (2027-2032) & (K Units) Table 178. Asia Etoricoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Asia Etoricoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Etoricoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Etoricoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Etoricoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Etoricoxib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. Asia Etoricoxib Sales by Country (2021-2026) & (K Units) Table 185. Asia Etoricoxib Sales by Country (2027-2032) & (K Units) Table 186. Asia Etoricoxib Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Asia Etoricoxib Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Japan Etoricoxib Revenue (2021-2032) & (US$ Million) Table 189. South Korea Etoricoxib Revenue (2021-2032) & (US$ Million) Table 190. India Etoricoxib Revenue (2021-2032) & (US$ Million) Table 191. Australia Etoricoxib Revenue (2021-2032) & (US$ Million) Table 192. China Taiwan Etoricoxib Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Etoricoxib Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Etoricoxib Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Etoricoxib Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Etoricoxib Sales by Type (2021-2026) & (K Units) Table 197. SAMEA Etoricoxib Sales by Type (2027-2032) & (K Units) Table 198. SAMEA Etoricoxib Sales Price by Type (2021-2026) & (US$/Unit) Table 199. SAMEA Etoricoxib Sales Price by Type (2027-2032) & (US$/Unit) Table 200. SAMEA Etoricoxib Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Etoricoxib Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Etoricoxib Sales by Application (2021-2026) & (K Units) Table 203. SAMEA Etoricoxib Sales by Application (2027-2032) & (K Units) Table 204. SAMEA Etoricoxib Sales Price by Application (2021-2026) & (US$/Unit) Table 205. SAMEA Etoricoxib Sales Price by Application (2027-2032) & (US$/Unit) Table 206. SAMEA Etoricoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Etoricoxib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Etoricoxib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Etoricoxib Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. SAMEA Etoricoxib Sales by Country (2021-2026) & (K Units) Table 211. SAMEA Etoricoxib Sales by Country (2027-2032) & (K Units) Table 212. SAMEA Etoricoxib Sales Price by Country (2021-2026) & (US$/Unit) Table 213. SAMEA Etoricoxib Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Brazil Etoricoxib Revenue (2021-2032) & (US$ Million) Table 215. Argentina Etoricoxib Revenue (2021-2032) & (US$ Million) Table 216. Chile Etoricoxib Revenue (2021-2032) & (US$ Million) Table 217. Colombia Etoricoxib Revenue (2021-2032) & (US$ Million) Table 218. Peru Etoricoxib Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Etoricoxib Revenue (2021-2032) & (US$ Million) Table 220. Israel Etoricoxib Revenue (2021-2032) & (US$ Million) Table 221. UAE Etoricoxib Revenue (2021-2032) & (US$ Million) Table 222. Turkey Etoricoxib Revenue (2021-2032) & (US$ Million) Table 223. Iran Etoricoxib Revenue (2021-2032) & (US$ Million) Table 224. Egypt Etoricoxib Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Etoricoxib Distributors List Table 228. Etoricoxib Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Etoricoxib Image Figure 2. Global Etoricoxib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etoricoxib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 120 mg Image Figure 5. 30 mg Image Figure 6. 60 mg Image Figure 7. 90 mg Image Figure 8. Global Etoricoxib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Etoricoxib Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Pharmacy Image Figure 12. Others Image Figure 13. Global Etoricoxib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Etoricoxib Revenue (2021-2032) & (US$ Million) Figure 15. Global Etoricoxib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Etoricoxib Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Etoricoxib Revenue Market Share by Region (2021-2032) Figure 18. Global Etoricoxib Sales (2021-2032) & (K Units) Figure 19. Global Etoricoxib Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Etoricoxib Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Etoricoxib Sales YoY (2021-2032) & (K Units) Figure 22. Europe Etoricoxib Sales YoY (2021-2032) & (K Units) Figure 23. China Etoricoxib Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Etoricoxib Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Etoricoxib Sales YoY (2021-2032) & (K Units) Figure 26. Global Etoricoxib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Etoricoxib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Etoricoxib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Etoricoxib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Etoricoxib Revenue Market Share by Type (2021-2032) Figure 32. Global Etoricoxib Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Etoricoxib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Etoricoxib Sales Market Share by Type (2021-2032) Figure 35. Global Etoricoxib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Etoricoxib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Etoricoxib Revenue Market Share by Application (2021-2032) Figure 38. Global Etoricoxib Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Etoricoxib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Etoricoxib Sales Market Share by Application (2021-2032) Figure 41. North America Etoricoxib Revenue Share by Type (2021-2032) Figure 42. North America Etoricoxib Sales Share by Type (2021-2032) Figure 43. North America Etoricoxib Revenue Share by Application (2021-2032) Figure 44. North America Etoricoxib Sales Share by Application (2021-2032) Figure 45. North America Etoricoxib Revenue Share by Country (2021-2032) Figure 46. North America Etoricoxib Sales Share by Country (2021-2032) Figure 47. Europe Etoricoxib Revenue Share by Type (2021-2032) Figure 48. Europe Etoricoxib Sales Share by Type (2021-2032) Figure 49. Europe Etoricoxib Revenue Share by Application (2021-2032) Figure 50. Europe Etoricoxib Sales Share by Application (2021-2032) Figure 51. Europe Etoricoxib Revenue Share by Country (2021-2032) Figure 52. Europe Etoricoxib Sales Share by Country (2021-2032) Figure 53. China Etoricoxib Revenue Share by Type (2021-2032) Figure 54. China Etoricoxib Sales Share by Type (2021-2032) Figure 55. China Etoricoxib Revenue Share by Application (2021-2032) Figure 56. China Etoricoxib Sales Share by Application (2021-2032) Figure 57. Asia Etoricoxib Revenue Share by Type (2021-2032) Figure 58. Asia Etoricoxib Sales Share by Type (2021-2032) Figure 59. Asia Etoricoxib Revenue Share by Application (2021-2032) Figure 60. Asia Etoricoxib Sales Share by Application (2021-2032) Figure 61. Asia Etoricoxib Revenue Share by Country (2021-2032) Figure 62. Asia Etoricoxib Sales Share by Country (2021-2032) Figure 63. SAMEA Etoricoxib Revenue Share by Type (2021-2032) Figure 64. SAMEA Etoricoxib Sales Share by Type (2021-2032) Figure 65. SAMEA Etoricoxib Revenue Share by Application (2021-2032) Figure 66. SAMEA Etoricoxib Sales Share by Application (2021-2032) Figure 67. SAMEA Etoricoxib Revenue Share by Country (2021-2032) Figure 68. SAMEA Etoricoxib Sales Share by Country (2021-2032) Figure 69. Etoricoxib Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Etoricoxib Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 120 mg
  • 30 mg
  • 60 mg
  • 90 mg
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Shanghai Shyndec Pharmaceutical
  • Qilu Pharmaceutical
  • Merck & Co
  • Easton Biopharmaceuticals
  • Beijing Tide Pharmaceutical
  • Morepen Laboratories
  • Metrochem API
  • Hema Pharmaceuticals
  • Frosst Iberica SA
  • Atom Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Etoricoxib Market by Type
  3. 1.2.1 Global Etoricoxib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 120 mg
  5. 1.2.3 30 mg
  6. 1.2.4 60 mg
  7. 1.2.5 90 mg
  8. 1.3 Etoricoxib Market by Application
  9. 1.3.1 Global Etoricoxib Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Pharmacy
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Etoricoxib Market Dynamics
  1. 2.1 Etoricoxib Industry Trends
  2. 2.2 Etoricoxib Industry Drivers
  3. 2.3 Etoricoxib Industry Opportunities and Challenges
  4. 2.4 Etoricoxib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Etoricoxib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Etoricoxib Revenue by Region
  3. 3.2.1 Global Etoricoxib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Etoricoxib Revenue by Region (2021-2026)
  5. 3.2.3 Global Etoricoxib Revenue by Region (2027-2032)
  6. 3.2.4 Global Etoricoxib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Etoricoxib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Etoricoxib Sales by Region
  9. 3.4.1 Global Etoricoxib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Etoricoxib Sales by Region (2021-2026)
  11. 3.4.3 Global Etoricoxib Sales by Region (2027-2032)
  12. 3.4.4 Global Etoricoxib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Etoricoxib Revenue by Manufacturers
  2. 4.1.1 Global Etoricoxib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Etoricoxib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Etoricoxib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Etoricoxib Sales by Manufacturers
  6. 4.2.1 Global Etoricoxib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Etoricoxib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Etoricoxib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Etoricoxib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Etoricoxib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Etoricoxib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Etoricoxib Manufacturers, Product Type & Application
  13. 4.7 Global Etoricoxib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Etoricoxib Market CR5 and HHI
  16. 4.8.2 2025 Etoricoxib Tier 1, Tier 2, and Tier 3
5 Etoricoxib Market by Type
  1. 5.1 Global Etoricoxib Revenue by Type
  2. 5.1.1 Global Etoricoxib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Etoricoxib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Etoricoxib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Etoricoxib Sales by Type
  6. 5.2.1 Global Etoricoxib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Etoricoxib Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Etoricoxib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Etoricoxib Price by Type
6 Etoricoxib Market by Application
  1. 6.1 Global Etoricoxib Revenue by Application
  2. 6.1.1 Global Etoricoxib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Etoricoxib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Etoricoxib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Etoricoxib Sales by Application
  6. 6.2.1 Global Etoricoxib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Etoricoxib Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Etoricoxib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Etoricoxib Price by Application
7 Company Profiles
  1. 7.1 Shanghai Shyndec Pharmaceutical
  2. 7.1.1 Shanghai Shyndec Pharmaceutical Company Information
  3. 7.1.2 Shanghai Shyndec Pharmaceutical Business Overview
  4. 7.1.3 Shanghai Shyndec Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai Shyndec Pharmaceutical Etoricoxib Product Portfolio
  6. 7.1.5 Shanghai Shyndec Pharmaceutical Recent Developments
  7. 7.2 Qilu Pharmaceutical
  8. 7.2.1 Qilu Pharmaceutical Company Information
  9. 7.2.2 Qilu Pharmaceutical Business Overview
  10. 7.2.3 Qilu Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Qilu Pharmaceutical Etoricoxib Product Portfolio
  12. 7.2.5 Qilu Pharmaceutical Recent Developments
  13. 7.3 Merck & Co
  14. 7.3.1 Merck & Co Company Information
  15. 7.3.2 Merck & Co Business Overview
  16. 7.3.3 Merck & Co Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck & Co Etoricoxib Product Portfolio
  18. 7.3.5 Merck & Co Recent Developments
  19. 7.4 Easton Biopharmaceuticals
  20. 7.4.1 Easton Biopharmaceuticals Company Information
  21. 7.4.2 Easton Biopharmaceuticals Business Overview
  22. 7.4.3 Easton Biopharmaceuticals Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Easton Biopharmaceuticals Etoricoxib Product Portfolio
  24. 7.4.5 Easton Biopharmaceuticals Recent Developments
  25. 7.5 Beijing Tide Pharmaceutical
  26. 7.5.1 Beijing Tide Pharmaceutical Company Information
  27. 7.5.2 Beijing Tide Pharmaceutical Business Overview
  28. 7.5.3 Beijing Tide Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Beijing Tide Pharmaceutical Etoricoxib Product Portfolio
  30. 7.5.5 Beijing Tide Pharmaceutical Recent Developments
  31. 7.6 Morepen Laboratories
  32. 7.6.1 Morepen Laboratories Company Information
  33. 7.6.2 Morepen Laboratories Business Overview
  34. 7.6.3 Morepen Laboratories Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Morepen Laboratories Etoricoxib Product Portfolio
  36. 7.6.5 Morepen Laboratories Recent Developments
  37. 7.7 Metrochem API
  38. 7.7.1 Metrochem API Company Information
  39. 7.7.2 Metrochem API Business Overview
  40. 7.7.3 Metrochem API Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Metrochem API Etoricoxib Product Portfolio
  42. 7.7.5 Metrochem API Recent Developments
  43. 7.8 Hema Pharmaceuticals
  44. 7.8.1 Hema Pharmaceuticals Company Information
  45. 7.8.2 Hema Pharmaceuticals Business Overview
  46. 7.8.3 Hema Pharmaceuticals Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hema Pharmaceuticals Etoricoxib Product Portfolio
  48. 7.8.5 Hema Pharmaceuticals Recent Developments
  49. 7.9 Frosst Iberica SA
  50. 7.9.1 Frosst Iberica SA Company Information
  51. 7.9.2 Frosst Iberica SA Business Overview
  52. 7.9.3 Frosst Iberica SA Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Frosst Iberica SA Etoricoxib Product Portfolio
  54. 7.9.5 Frosst Iberica SA Recent Developments
  55. 7.10 Atom Pharma
  56. 7.10.1 Atom Pharma Company Information
  57. 7.10.2 Atom Pharma Business Overview
  58. 7.10.3 Atom Pharma Etoricoxib Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Atom Pharma Etoricoxib Product Portfolio
  60. 7.10.5 Atom Pharma Recent Developments
8 North America
  1. 8.1 North America Etoricoxib Market Size by Type
  2. 8.1.1 North America Etoricoxib Revenue by Type (2021-2032)
  3. 8.1.2 North America Etoricoxib Sales by Type (2021-2032)
  4. 8.1.3 North America Etoricoxib Price by Type (2021-2032)
  5. 8.2 North America Etoricoxib Market Size by Application
  6. 8.2.1 North America Etoricoxib Revenue by Application (2021-2032)
  7. 8.2.2 North America Etoricoxib Sales by Application (2021-2032)
  8. 8.2.3 North America Etoricoxib Price by Application (2021-2032)
  9. 8.3 North America Etoricoxib Market Size by Country
  10. 8.3.1 North America Etoricoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Etoricoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Etoricoxib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Etoricoxib Market Size by Type
  2. 9.1.1 Europe Etoricoxib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Etoricoxib Sales by Type (2021-2032)
  4. 9.1.3 Europe Etoricoxib Price by Type (2021-2032)
  5. 9.2 Europe Etoricoxib Market Size by Application
  6. 9.2.1 Europe Etoricoxib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Etoricoxib Sales by Application (2021-2032)
  8. 9.2.3 Europe Etoricoxib Price by Application (2021-2032)
  9. 9.3 Europe Etoricoxib Market Size by Country
  10. 9.3.1 Europe Etoricoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Etoricoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Etoricoxib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Etoricoxib Market Size by Type
  2. 10.1.1 China Etoricoxib Revenue by Type (2021-2032)
  3. 10.1.2 China Etoricoxib Sales by Type (2021-2032)
  4. 10.1.3 China Etoricoxib Price by Type (2021-2032)
  5. 10.2 China Etoricoxib Market Size by Application
  6. 10.2.1 China Etoricoxib Revenue by Application (2021-2032)
  7. 10.2.2 China Etoricoxib Sales by Application (2021-2032)
  8. 10.2.3 China Etoricoxib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Etoricoxib Market Size by Type
  2. 11.1.1 Asia Etoricoxib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Etoricoxib Sales by Type (2021-2032)
  4. 11.1.3 Asia Etoricoxib Price by Type (2021-2032)
  5. 11.2 Asia Etoricoxib Market Size by Application
  6. 11.2.1 Asia Etoricoxib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Etoricoxib Sales by Application (2021-2032)
  8. 11.2.3 Asia Etoricoxib Price by Application (2021-2032)
  9. 11.3 Asia Etoricoxib Market Size by Country
  10. 11.3.1 Asia Etoricoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Etoricoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Etoricoxib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Etoricoxib Market Size by Type
  2. 12.1.1 SAMEA Etoricoxib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Etoricoxib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Etoricoxib Price by Type (2021-2032)
  5. 12.2 SAMEA Etoricoxib Market Size by Application
  6. 12.2.1 SAMEA Etoricoxib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Etoricoxib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Etoricoxib Price by Application (2021-2032)
  9. 12.3 SAMEA Etoricoxib Market Size by Country
  10. 12.3.1 SAMEA Etoricoxib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Etoricoxib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Etoricoxib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Etoricoxib Value Chain Analysis
  2. 13.1.1 Etoricoxib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Etoricoxib Production Mode & Process
  6. 13.2 Etoricoxib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Etoricoxib Distributors
  9. 13.2.3 Etoricoxib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst